European trends in breast cancer mortality, 1980–2017 and predictions to 2025

Wojtyła, Cezary; Bertuccio, Paola; Wojtyła, Andrzej; Vecchia, Carlo La

doi:10.1016/j.ejca.2021.04.026

Cited by 65 publications

(49 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, Wojtyla et al did not analyze trends in BC mortality by 5-year age groups. 34 According to Carioli et al, reduction in overall BC mortality was the smallest within the European Union; similarly, in a study by Malvezzi, OC mortality in 2002–2012 showed a small reduction. 35 , 36 In the first decade of the 21st century, a reversal in the CUC mortality trend, from declining or stable to significantly increasing or an acceleration of an increasing trend, was found in all women age ≥50 years.…”

Section: Discussionmentioning

confidence: 92%

Trends in Incidence and Mortality of Gynecological and Breast Cancers in Poland (1980–2018)

Piechocki¹,

Koziołek²,

Sroka³

et al. 2022

CLEP

View full text Add to dashboard Cite

Background This study aimed to analyze and determine the incidence and mortality trends in gynecological and breast cancers (BCs) in Poland. The gynecological cancers assessed were cervical cancer (CC), corpus uteri cancer (CUC), ovarian cancer (OC), vaginal cancer (VAC), and vulvar cancer (VUC). Patients and Methods Data concerning the incidence and mortality for the period of 1980–2018 were obtained from the Polish National Cancer Registry (PNCR). Joinpoint regression analysis was performed to identify trends, which were described using the annual percentage change (APC) and the average annual percent change (AAPC). Results Statistically significant increases were observed in BC incidence (AAPC: 2.3; CI: 1.8 to 2.9; p<0.05), CUC incidence (AAPC: 2.3; CI: 1.9 to 2.7; p<0.05), CUC mortality (AAPC: 0.4; CI: 0.1 to 0.7; p<0.05) and VUC mortality (AAPC: 1.16, CI: 0.1 to 2.2; p<0.05). VAC mortality decreased (AAPC: −3.5, CI: −5.0 to –2.0; p<0.05), as did CC incidence and mortality (AAPC: −2.1, CI: −2.3 to −1.8; p<0.05, AAPC: −2.0, CI: −2.2 to –1.8; p<0.05, respectively). Between 1980 and 1993, OC incidence initially increased and then stabilized (AAPC: 0.9; CI: 0.7 to 1.1; p<0.05). After 2007, OC mortality decreased (AAPC: 0.0; CI: −0.2 to 0.2; p=0.8). Trends in VUC and VAC incidence and BC mortality were not statistically significant. Conclusion The results of this study showed a significant increase in OC, CUC, and BC incidence, and a decrease in the incidence of CC and VAC. The VUC trends were stable. Mortality trends for BC initially fluctuated and, since 2010, has begun to increase. Throughout the observed period, mortality due to VUC and CUC increased, whereas decreased among patients with CC. OC mortality was stable, but not significant. Furthermore, the study showed a correlation between age group and rate of incidence and mortality of each assessed cancer.

show abstract

Section: Discussionmentioning

confidence: 92%

Trends in Incidence and Mortality of Gynecological and Breast Cancers in Poland (1980–2018)

Piechocki¹,

Koziołek²,

Sroka³

et al. 2022

CLEP

View full text Add to dashboard Cite

show abstract

“…Similarly, Baeyens-Fernández et al, found a five-year survival rate in Granada (Spain) of 83.7% in a cohort of women with a BC diagnosed in 2010-2012 (n = 8.502) [22]. Nevertheless, the overall survival rate after BC was lower than Northern European countries, the USA or Australia [23,24], probably due to a socioeconomic gap in favor of these countries, which conditions more innovative treatment options, better established screening programs and more advanced diagnoses [25]. The lower survival rate in Spain is important to understand our findings related to the lower survival of Spanish women with BC and T2DM [17], which is the age group with higher mortality rates after BC, according to our results, their survival rate may have been overestimated.…”

Section: Discussionmentioning

confidence: 99%

Type 2 Diabetes and all-cause mortality among Spanish women with breast cancer

Fernández-Arce

Robles-Rodríguez

Fernández-Feito

et al. 2021

Cancer Causes Control

View full text Add to dashboard Cite

Purpose To explore the effect of type 2 diabetes mellitus (T2DM) on the risk of death among women with breast cancer (BC). Methods A survival analysis was conducted among a cohort of women diagnosed with BC between 2006 and 2012 in Spain (n = 4,493). Biopsy or surgery confirmed BC cases were identified through the state population-based cancer registry with information on patients’ characteristics and vital status. Physician-diagnosed T2DM was confirmed based on primary health care clinical history. Cox regression analyses were used to estimate adjusted hazard ratios (aHR) and 95% confidence intervals (CI) for all-cause death. Analyses were adjusted for age, hospital size, several clinical characteristics (including BC stage and histology, among others) and treatment modalities. Results Among the 4,493 BC women, 388 (8.6%) had coexisting T2DM. Overall, 1,299 (28.9%) BC women died during the completion of the follow-up and 785 (17.5%) did so during the first five years after BC diagnosis, resulting in a five-year survival rate of 82.5%. The death rate was higher in women with T2DM (43.8% died during whole period and 26.0% during the first five years) when compared with women without T2DM (27.5% and 16.7%, respectively). Accordingly, all-cause mortality was higher in women with T2DM (aHR: 1.22; 95% CI 1.03–1.44), especially if T2DM was diagnosed before BC (aHR:1.24; 95% CI 1.03–1.50) and in women with BC diagnosed before 50 years (aHR: 2.38; 95% CI 1.04–5.48). Conclusions T2DM was associated with higher all-cause mortality among Spanish women with BC, particularly when the T2DM diagnosis was prior to the BC.

show abstract

“…All these factors should be considered during the implementation of subsequent national preventive programs, especially for women with reduced values of assets. Financial support for these women is essential, especially in current times, when increasing mortality and morbidity of breast cancer in Poland is observed [ 30 ].…”

Section: Discussionmentioning

confidence: 99%

How Sociodemographic Factors Impact the Utilization of Recommended Clinical Preventive Screening Services in Poland: A Nationwide Cross-Sectional Study

Agrawal

Makuch

Lachowicz

et al. 2021

IJERPH

View full text Add to dashboard Cite

Cardiovascular disease (CVD) and cancer are the most frequent causes of mortality in Poland. To date, no study in Poland has attempted to analyze the impact of sociodemographic factors on the utilization of all recommended preventive services for these diseases. To address this challenge, a nationwide cross-sectional study was conducted. One thousand adults aged 18 years or older were interviewed using computer-assisted telephone surveys conducted via random selection. A representative population was obtained in accordance with existing demographics per voivodeship in Poland. We assessed whether factors such as age, gender, body mass index (BMI), net income, household size, place of residence, and education impacted the odds ratio of utilizing recommended preventive services for CVD and cancer. We determined that elderly patients receive influenza vaccination, measure blood pressure, PSA concentration, glucose and lipid profiles, and undergo colonoscopy and mammography more often than younger counterparts. Men were more often influenza vaccinated (OR = 1.56, 95% CI: 1.07–2.27) than women, while women measured blood glucose more often than men (OR = 0.62, 95% CI: 0.42–0.93). Furthermore, net income < 2000 PLN, BMI < 24 kg/m2 and at least secondary education level were found to be crucial predictors of undergoing mammography (OR = 2.16; 95% CI: 1.26–3.72), cervical smear tests (OR = 1.99, 95% CI: 1.24–3.17), and lipid measurements (OR = 1.76, 95% CI: 1.07–2.91), respectively. Educating people and financial support seem to play a crucial role in implementing novel campaigns and preventive programs in Poland. Addressing each significant factor may be of paramount importance in improving the receipt of preventive services and warranting greater preventive care coverage in the Polish population.

show abstract

European trends in breast cancer mortality, 1980–2017 and predictions to 2025

Cited by 65 publications

References 32 publications

Trends in Incidence and Mortality of Gynecological and Breast Cancers in Poland (1980–2018)

Trends in Incidence and Mortality of Gynecological and Breast Cancers in Poland (1980–2018)

Type 2 Diabetes and all-cause mortality among Spanish women with breast cancer

How Sociodemographic Factors Impact the Utilization of Recommended Clinical Preventive Screening Services in Poland: A Nationwide Cross-Sectional Study

Contact Info

Product

Resources

About